← back to search

Michael D. Devous

The University of Texas Southwestern Medical Center · GB
Area of research
Psychiatry and Mental health · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments, Medical Imaging Techniques and Applications, and Functional Brain Connectivity Studies.
h-index
79
citations
21,640
works
361
NIH funding
primary concept
Medicine
email

Recent publications

Four distinct trajectories of tau deposition identified in Alzheimer’s disease
Nature Medicine 2021cited by 716position: middledoi
Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease
JAMA Neurology 2021cited by 305position: middledoi
Positron Emission Tomography Imaging With [<sup>18</sup>F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes
JAMA Neurology 2020cited by 438position: middledoi
The impact of demographic, clinical, genetic, and imaging variables on tau PET status
European Journal of Nuclear Medicine and Molecular Imaging 2020cited by 50position: middledoi
Tau Positron-Emission Tomography in Former National Football League Players
New England Journal of Medicine 2019cited by 213position: middledoi
Standardization of amyloid quantitation with florbetapir standardized uptake value ratios to the Centiloid scale
Alzheimer s & Dementia 2018cited by 217position: lastdoi
<sup>18</sup>F‐flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study
Annals of Neurology 2017cited by 175position: middledoi
Revolutionizing Alzheimer's disease and clinical trials through biomarkers
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring 2015cited by 104position: middledoi
The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET
Alzheimer s & Dementia 2014cited by 1,285position: middledoi
Altered Neural Processing of Threat in Alcohol-Dependent Men
Alcoholism Clinical and Experimental Research 2013cited by 27position: middledoi
Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline
Neurology 2012cited by 228position: middledoi
Predicting missing biomarker data in a longitudinal study of Alzheimer disease
Neurology 2012cited by 49position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Michael J. Pontecorvo · Eli Lilly (United States)4 papers (2014–2021)Mark A. Mintun · Resonance Research (United States)3 papers (2014–2019)Keith A. Johnson · Howard University2 papers (2014–2017)Christopher C. Rowe · University of Lübeck2 papers (2014–2018)William E. Klunk · University of Pittsburgh2 papers (2014–2018)Gil D. Rabinovici · Harvard University2 papers (2017–2021) · 2 papers (2018–2019)William J. Jagust · Berkeley College2 papers (2014–2017)Davneet Minhas · University of Pittsburgh1 papers (2014–2014)Andrew Siderowf · University of Pennsylvania1 papers (2017–2017)Joseph R. Winer · Palo Alto University1 papers (2017–2017)William W. Seeley · Hammersmith Hospital1 papers (2017–2017)Julie C. Price · Harvard University1 papers (2014–2014)Neil P. Oxtoby · Energy Institute1 papers (2021–2021)Erik D. Roberson · University of California, Davis1 papers (2017–2017)Martha E. Shenton · Brigham and Women's Hospital1 papers (2019–2019) · 1 papers (2015–2015)Robert A. Koeppe · Johannes Kepler University of Linz1 papers (2014–2014)Jacob W. Vogel · Malmö University1 papers (2021–2021)Hongyu Yang · Shenyang Pharmaceutical University1 papers (2013–2013)